International Rare Diseases Research Consortium Conference In China
The 2nd International Rare Diseases Research Consortium (IRDiRC) Conference, is scheduled for November 7 – 9, 2014, in Shenzhen, China. The conference, co-organized by BGI, is gathering global stakeholders active in the field of rare diseases, with the purpose of fostering greater international collaborations involving Chinese researchers and clinicians.
Four parallel tracks are organized over two conference days:
An additional training course day is dedicated to the enrichment of knowledge and scientific endeavors in rare disease research.
The conference provides opportunities to network with different rare disease communities from Europe, North and South America, Africa, and Asia-Pacific. It creates the largest stage in the rare disease field and aims to gather around 1,000 participants, including researchers, medical doctors, clinicians, hospitals, pharmaceutical companies, patient organizations, and non-governmental organizations (NGOs) from around the world, supported by more than 40 domestic and international media.
• Karen Aiach, Founding President/CEO, Lysogene
• Ségolène Aymé, Coordinator/Emeritus Director of Research, IRDiRC
• Seng Cheng, Head of R&D, Rare Diseases, Genzyme (Sanofi)
• Yann Le Cam, CEO, EURORDIS.
A list of additional Speakers is available here.
The IRDiRC program is available here.
To register please access the IRDiRC website.
For more information, please email firstname.lastname@example.org either in English or in Chinese.
IRDiRC Meeting Logo courtesy of BGI.
Copyright © 2012-2014, Orphan Druganaut Blog. All rights reserved.